Impairment of peroxisomal biogenesis in human colon carcinoma

Carcinogenesis

Volumn 20, Issue 6, 1999, Pages 985-989

  Lauer, Christoph ^a   Völkl, Alfred ^a   Riedl, Stefan ^b   Fahimi, H Dariush ^a   Beier, Konstantin ^c  

^a Inst fur Anat und Zellbiologie III   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A OXIDASE; CATALASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RECEPTOR PROTEIN;

ARTICLE; BIOGENESIS; COLON CARCINOMA; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NORTHERN BLOTTING; PEROXISOME; PRIORITY JOURNAL; RIBONUCLEASE PROTECTION ASSAY; WESTERN BLOTTING;

ACYL-COA OXIDASE; ADENOCARCINOMA; ATP-BINDING CASSETTE TRANSPORTERS; CATALASE; COLONIC NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MICROBODIES; OXIDOREDUCTASES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 0345211519     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.6.985     Document Type: Article

References (52)

1. Singh, I. (1997) Biochemistry of peroxisomes in health and disease. Mol. Cell. Biochem., 167, 1-29.
2. Mannaerts, G.P. and van Veldhoven, P.P. (1996) Functions and organization of peroxisomal beta-oxidation. Ann. NY Acad. Sci., 804, 99-115.
3. Diczfalusy, U., Kase, B.F., Alexson, S.E.H. and Bjorkhem, I. (1991) Metabolism of prostaglandin-F2α in Zellweger syndrome - peroxisomal β-oxidation is of major importance for in vivo degradation of prostaglandins in humans. J. Clin. Invest., 88, 978-984.
4. Appelkvist, E.L., Reinhart, M., Fischer, R., Billheimer, J. and Dallner, G. (1990) Presence of individual enzymes of cholesterol biosynthesis in rat liver peroxisomes. Arch. Biochem. Biophys., 282, 318-325.
5. Krisans, S.K. (1996) Cell compartmentalization of cholesterol biosynthesis. Ann. NY Acad. Sci., 804, 142-164.
6. Garg, M.L. and Haerdi, J.C. (1993) The biosynthesis of plasmalogens. J. Clin. Biochem. Nutr., 14, 71-82.
7. Hajra, A.K. and Das, A.K. (1996) Lipid biosynthesis in peroxisomes. Ann. NY Acad. Sci., 804, 129-141.
8. Van den Bosch, H., Schutgens, R.B.H., Wanders, R.J.A. and Tager, J.M. (1992) Biochemistry of peroxisomes. Annu. Rev. Biochem., 61, 157-197.
9. Blumenthal, F. and Brahn, B. (1910) Die Katalasewirkung in normaler und in carcinomatöser Leber. Z. Krebsforsch., 8, 436-440.
10. Goldfischer, S. and Reddy, J.K. (1984) Peroxisomes (microbodies) in cell pathology. Int. Rev. Exp. Pathol., 26, 45-84.
11. Ohnuma, T., Maldia, G. and Holland, J.F. (1966) Hepatic catalase activity in advanced human cancer. Cancer Res., 26, 1806-1818.
12. El Bouhtoury, F., Keller, J.M., Colin, S., Parache, R.M. and Dauca, M. (1992) Peroxisomal enzymes in normal and tumoral human breast. J. Pathol., 166, 27-35.
13. Yokoyama, Y. Tsuchida, S., Hatayama, I., Satoh, K., Narita, T., Rao, M.S., Reddy, J.K., Yamada, J., Suga, T. and Sato, K. (1992) Loss of peroxisomal enzyme expression in preneoplastic and neoplastic lesions induced by proliferators in rat livers. Carcinogenesis, 13, 265-269.
14. Yamaguchi, Y., Sato, K. and Endo, H. (1992) Depression of catalase gene expression in the liver of tumor bearing nude mice. Biochem. Biophys. Res. Commun., 189, 1084-1089.
15. Sato, K., Ito, K., Kohara, H., Yamaguchi, Y., Adachi, K. and Endo, H. (1992) Negative regulation of catalase gene expression in hepatoma cells. Mol. Cell Biol., 12, 2525-2533.
16. De Craemer, D., Pauwels, M., Hautekeete, M. and Roels, F. (1993) Alterations of hepatocellular peroxisomes in patients with cancer. Cancer, 71, 3851-3858.
17. De Craemer, D., Pauwels, M., Vergeylen, A., Roels, F. and Van den Branden, C. (1993) Peroxisomes in liver, kidney and duodenum of nude mice bearing xenografts of human pancreatic adenocarcinomas. Virchows Arch. [B], 64, 7-12.
18. Grasl-Kraupp, B., Huber, W., Just, W., Gibson, G. and Schulte-Hermann, R. (1993) Enhancement of peroxisomal enzymes, cytochrome-P-452 and DNA synthesis in putative preneoplastic foci of rat liver treated with the peroxisome proliferator nafenopin. Carcinogenesis, 14, 1007-1012.
19. Keller, J.M., Cable, S., El Bouhtoury, F., Heusser, S., Scotto, C., Armbruster, L., Ciolek, E., Colin, S., Schilt, J. and Dauca, M. (1993) Peroxisome through cell differentiation and neoplasia. Biol. Cell, 77, 72-88.
20. Sun, Y., Colburn, N.H. and Oberley, L.W. (1993) Depression of catalase gene expression after immortalization and transformation of mouse liver cells. Carcinogenesis, 14, 1505-1510.
21. Baur, G. and Wendel, A. (1980) The activity of the peroxide-metabolizing system in human colon carcinoma. J. Cancer Res. Clin. Oncol., 97, 267-273.
22. Cable, S., Keller, J.M., Colin, S., Haffen, K., Kedinger, M., Parache, R.M. and Dauca, M. (1992) Peroxisomes in human colon carcinomas. A cytochemical and biochemical study. Virchows Arch. [B], 62, 221-226.
23. Schoonjans, K., Martin, G., Staels, B. and Auwerx, J. (1997) Peroxisome proliferator-activated receptors, orphans with ligands and functions. Curr. Opin. Lipidol., 8, 159-166.
24. Brockman, J.A., Gupta, R.A. and DuBois, R.N. (1998) Activation of PPARα leads to inhibition of anchorage-independent growth of human colorectal cancer cells. Gastroenterology, 115, 1049-1055.
25. Sarraf, P., Mueller, E., Jones, D., King, F.J., DeAngelo, D.J., Partridge, J.B., Holden, S.A., Chen, L.B., Singer, S., Fletcher, C. and Spiegelman, B.M. (1998) Differentiation and reversal of malignant changes in colon cancer through PPARα [see comments]. Nature Med., 4, 1046-1052.
26. Min/+ mice. Nature Med., 4, 1053-1057.
27. Saez, E., Tontonoz, P., Nelson, M.C., Alvarez, J.G., Ming, U.T., Baird, S.M., Thomazy, V.A. and Evans, R.M. (1998) Activators of the nuclear receptor PPARα enhance colon polyp formation. Nature Med., 4, 1058-1061.
28. Subramani, S. (1998) Components involved in peroxisome import, biogenesis, proliferation, turnover, and movement. Physiol. Rev., 78, 171-188.
29. Lehmann, T., Völkl, A. and Fahimi, H.D. (1995) The importance of tissue fixation for light microscopic immunohistochemial localization of peroxisomal proteins: the superiority of Carnoy's fixative over Baker's formalin and Bouin's solution. Histochemistry, 103, 187-195.
30. Beier, K., Völkl, A., Hashimoto, T. and Fahimi, H.D. (1988) Selective induction of peroxisomal enzymes by the hypolipidemic drug bezafibrate. Detection of modulations by automatic image analysis in conjunction with immunoelectron microscopy and immunoblotting. Eur. J. Cell. Biol., 46, 383-393.
31. Beier, K., Völkl, A., Metzger, C., Mayer, D., Bannasch, P. and Fahimi, H.D. (1997) Hepatic zonation of the induction of cytochrome P450 IVA, peroxisomal lipid beta-oxidation enzymes and peroxisome proliferation in rats treated with dehydroepiandrosterone (DHEA). Evidence of distinct zonal and sex-specific differences. Carcinogenesis, 18, 1491-1498.
32. Beier, K., Völkl, A. and Fahimi, H.D. (1997) TNFα downregulates the peroxisome proliferator activated receptor-alpha and the mRNAs encoding peroxisomal proteins in rat liver. FEBS Lett., 412, 385-387.
33. Zhan, J., Fahimi, H.D. and Völkl, A. (1997) Sensitive nonradioactive dot blot/ribonuclease protection assay for quantitative determination of mRNA. BioTechniques, 22, 500-505.
34. Inestrosa, N.C, Bronfman, M. and Leighton, F. (1979) Detection of peroxisomal acyl-coenzyme A oxidase activity. Biochem. J., 182, 779-788.
35. Braissant, O., Foufelle, F., Scotto, C., Dauca, M. and Wahli, W. (1996) Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPARα, -β and -γ in the adult rat. Endocrinology, 137, 354-366.
36. DuBois, R.N., Gupta, R., Brockman, J., Reddy, B.S., Krakow, S.L. and Lazar, M.A. (1998) The nuclear eicosanoid receptor, PPARγ, is aberrantly expressed in colonie cancers. Carcinogenesis, 19, 49-53.
37. Kliewer, S.A., Forman, B.M., Blumberg, B., Ong, E.S., Borgmeyer, U., Mangelsdorf, D.J., Umesono, K. and Evans, R.M. (1994) Differential expression and activation of a family of murine peroxisome proliferator-activaled receptors. Proc. Natl Acad, Sci. USA, 91, 7355-7359.
38. Klausner, R.D., Rouault, T.A. and Harford, J.B. (1993) Regulating the fate of mRNA: the control of cellular iron metabolism. Cell, 72, 19-28.
39. Bommer, U.A., Lazaris-Karatzas, A., De Benedetti, A., Nurnberg, P., Benndorf, R., Bielka, H. and Sonenberg, N. (1994) Translational regulation of the mammalian growth-related protein P23: involvement of eIF-4E. Cell. Mol. Biol. Res., 40, 633-641.
40. Chu, E. and Allegra, C.J. (1996) The role of thymidylate synthase in cellular regulation. Adv. Enzyme Regulat., 36, 143-163.
41. Leppa, S., Vleminckx, K., Van, Roy-F. and Jalkanen, M. (1996) Syndecan-1 expression in mammary epithelial tumor cells is E-cadherin-dependent. J. Cell Sci., 109, 1393-1403.
42. Nordengren, J., Casslen, B., Gustavsson, B., Einarsdottir, M. and Willen, R. (1998) Discordant expression of mRNA and protein for urokinase and tissue plasminogen activators (u-PA, t-PA) in endometrial carcinoma. Int. J. Cancer, 79, 195-201.
43. Lazarow, P.B. and Fujiki, Y. (1985) Biogenesis of peroxisomes. Annu. Rev. Cell Biol., 1, 489-530.
44. McNew, J.A. and Goodman, J.M. (1996) The targeting and assembly of peroxisomal proteins: some old rules do not apply. Trends Biochem. Sci., 21, 54-58.
45. Moser, H.W. and Moser, A.B. (1996) Peroxisomal disorders: overview. Ann. NY Acad. Sci., 804, 427-441.
46. Slawecki, M.L., Dodt, G., Steinberg, S., Moser, A.B., Moser, H.W. and Gould, S.J. (1995) Identification of three distinct peroxisomal protein import defects in patients with peroxisome biogenesis disorders. J. Cell Sci., 108, 1817-1829.
47. Baes, M., Gressens, P., Baumgart, E., Carmeliet, P., Casteels, M., Fransen, M., Evrard, P., Fahimi, H.D., Declercq, P.E., Collen, D., vanVeldhoven, P.P. and Mannaerts, G.P. (1997) A mouse model for Zellweger syndrome. Nature Genet., 17, 49-57.
48. Kaldi, K., Diestelkotter, P., Stenbeck, G., Auerbach, S., Jakle, U., Magert, H.J., Wieland, F.T. and Just, W.W. (1993) Membrane topology of the 22 kDa integral peroxisomal membrane protein. FEBS Lett., 315, 217-222.
49. Bryant, D.D. and Wilson, G.N. (1995) Differential evolution and expression of murine peroxisomal membrane protein genes. Biochem. Mol. Med., 55, 22-30.
50. Dodt, G. and Gould, S.J. (1996) Multiple PEX genes are required for proper subcellular distribution and stability of Pex5p, the PTS1 receptor: evidence that PTS1 protein import is mediated by a cycling receptor. J. Cell Biol., 135, 1763-1774.
51. Just, W.W. and Diestelkotter, P. (1996) Protein insertion into the peroxisomal membrane. Ann. NY Acad. Sci., 804, 60-75.
52. Pause, B., Diestelkotter, P., Heid, H. and Just, W.W. (1997) Cytosolic factors mediate protein insertion into the peroxisomal membrane. FEBS Lett., 414, 95-98.